News Releases
Mar 8 2022
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments
Mar 1 2022
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022
Jan 10 2022
Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility
Dec 7 2021
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments
Nov 30 2021
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021
Nov 4 2021
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies
Oct 26 2021
Avid Bioservices to Join S&P SmallCap 600 Index
Oct 14 2021
Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy
Oct 7 2021
Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial Officer
Sep 8 2021
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent Developments